Sobre la prevención del ACV. Del ACV no cardioembólico
Biografía del autor/a
Germán Enrique Pérez, Universidad Nacional de Colombia
.
Referencias bibliográficas
CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997 Jun 7;349(9066):1641-1649.
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1977; 349(9065):1569-1581.
Collaborative overview of randomized trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308(6921):81-106.
ADAMS HP, DEL ZOPPO G, ALBERTS MJ, DEEPAK LB, BRASS L, FURLAN A, GRUBB RG, ET AL. Guidelines for the Early Manegement of Adults with Ischemic Stroke. Stroke 2007;38:1655-1711
A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348(9038):1329-1339.
DIENER HC, SACCO RL, YUSUF, COTTON D, OONPUU S, LAWTON WA, ALBERS GW. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008; 7:875-784.
CHEN J, BHATT DL, DUNN ES, SHI C, CARO JJ, MAHONEY EM, GABRIEL S, JACKSON JD, TOPOL EJ, COHEN DJ. Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial. Value Health 2009 12:872-879.
HEEG B, DAMEN J, VAN HOUT B. Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective. Pharmacoeconomics 2007; 25:1063-1082.
Cilostazol Bests Aspirin for Secondary Stroke Prevention in Some Patients: Presented at ESC. http://www.docguide.com/news/content.nsf/news/852576140048867C8525773000711868 (Visitado en Junio 20 de 2010).
UCHIYAMA S, DEMAERSCHALK BM, GOTO S, SHINOHARA Y, GOTOH F, STONE WM, MONEY SR, KWON SU. Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. Stroke Cerebrovasc Dis 2009 ;18(6):482.
GOLDSTEIN LB, ADAMS R, ALBERTS MJ, APPEL LJ, BRASS LM, BUSHNELL CD, CULEBRAS A, ET AL. Primary Prevention of Ischemic Stroke. Stroke 2006;37:1583-1633
CONNOLLY SJ, POGUE J, HART RG, HOHNLOSER SH, PFEFFER M, CHROLAVICIUS S, YUSUF S. ACTIVE Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation's 2009; 360:2066-2078.
Cómo citar
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2023 Acta Neurológica Colombiana

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores renuncian al control y a los derechos de publicación de manuscritos, cediendo a Acta Neurológica Colombiana sus derechos, incluyendo la publicación en Internet y en medios magnéticos.
Todos los derechos incluidos en Acta Neurológica Colombiana están protegidos por derechos de autor. Conforme a la ley, esta prohibida su reproducción por cualquier medio mecánico o electrónico, sin permiso escrito del autor y los editores.
La responsabilidad de los conceptos que se publiquen es íntegramente del autor, y Acta Neurológica Colombiana no asume ninguna por ellos.
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |













